PAGE 7
HIV NUTRITION UPDATE
VOLUME 7, ISSUE 5
Selenium And HIV Disease

(Continued from page 6)
 

SELENIUM SUPPLEMENTATION

We know the healthy U.S. recommended dietary allowance (RDA) for selenium intake is 55 µg/day for men and women over the age of 19 years. (67) Yet, current RDAs may not reflect true requirements, which can vary depending upon dietary intake and physiological state. The average daily intake of selenium from foods in the United States is about 100 µg.
 
 

Ingestion of excessive amounts of selenium can result in various conditions (Table 3). (2, 4, 5, 68) Schrauzer and Sacher note continuous administration of selenium at high doses (1 mg/day) can have an immunosuppressive effect and increase the release of tumor necrosis factor alpha or other inhibitors associated with the processes leading to CD4 T-cell depletion. (69) Considerably more information is available on animal toxicity than human toxicity. However, selenium-induced lesions among all species are similar, illustrating a positive corollary for selenium effects in both animals and humans. Epidemiological data from China describe a syndrome of selenium toxicity manifested by cracked fingernails and extensive hair loss. (70) The Lowest-Observed-Adverse-Effects-Level (LOAEL) for selenium in adults is 900 µg daily; intakes of selenium less than 900 µg/day (for adults) are unlikely to result in selenium toxicosis. The selenium upper intake limit however, is set at 400 µg/day. The toxicity of selenium depends upon the chemical form of selenium ingested and upon the selenium levels in the foods consumed. There are no known interactions with drugs in clinical practice. Interactions may occur, however, with other nutrients such as the potentiation of antioxidant activity of tocopherols and decreased selenium bioavailability in the presence of vitamin C. (71)


 
 
 
TABLE 3. EFFECTS OF EXCESSIVE SUPPLEMENTATION 
Abdominal pain Acute Respiratory Distress Syndrome Diarrhea
Fatigue Changes in nail structure Hair/nail loss
Irritability Garlic odor in breath and sweat Nausea
Gastrointestinal irritation Mottling of the teeth Metallic taste
Myocardial infarction Nervous system lesions 
Neurological disturbance Peripheral neuropathy 
Renal failure Skin lesions Weakness

 
 

 

Recommendation: Taylor notes, "...supplementation is likely to be necessary and beneficial, at least in some cases". (2) Even though it seems advisable to consider some level of supplementation, patients should consult with their doctors before adding selenium to their daily regimen. Since few studies report on dietary intake of selenium, it is difficult to assess the extent to which the decreased selenium status of PLWHIV is due to dietary intake or metabolic changes associated with HIV-infection. Based upon reported  correction of selenium deficiency at doses of 100 to 500 µg selenium supplementation daily and the ability of these doses to restore antioxidant function in PLWHIV and influence clinical outcome, it is reasonable to suggest selenium supplementation in PLWHIV should be 100 to 200 µg/day. A dose of 400 µg/day seems reasonable for patients with impaired absorption. (2) Taking up to 800 µg/day for a few weeks to get blood levels up, followed by 400 µg/day seems reasonable for those demonstrably deficient in selenium. It is best to take selenium with a good multivitamin to help offset imbalances that may occur in other trace minerals. 
(Continued on page 8)


 
 

 
 
Copyright 2003 HIV ReSources, Inc. Sharing this newsletter in any form with non-subscribers is strictly prohibited. Library/Institution subscribers are permitted to share HIV Nutrition Update html newsletter pages with up to five (5) employees or volunteers. NO other redistribution allowed. 
 
Please Help To Keep This Page Updated By Notifying
The Webmaster If You Find A Link That's Outdated!
 
HIV ReSources, Inc.
PO Box 39385
Fort Lauderdale, FL
33339-9385
USA
 
© 2003  HIV ReSources, Inc.
Any use of the information presented herein is done strictly at your own risk.
No responsibility is implied or intended on the part of HIV ReSources Inc,
the editor, or the publisher. Information on this site should not
be construed as an endorsement of any kind.
 
3/30/2003